ProMIS Neurosciences Inc. (PMN) — Strategic Asset Allocation Index
ProMIS Neurosciences Inc. (PMN) has a Strategic Asset Allocation Index of 0.0% as of December 2022. Strategic assets (PP&E of $321.00 plus long-term investments of $-) total $321.00, measured against net assets of $692.68K. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See ProMIS Neurosciences Inc. net asset quality index to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
ProMIS Neurosciences Inc. Strategic Asset Allocation Index (2018–2021)
This chart shows how ProMIS Neurosciences Inc.'s Strategic Asset Allocation Index has evolved across 3 annual periods from 2018 to 2021. As of December 2022, the index stands at 0.0%, representing strategic assets of $321.00 against net assets of $692.68K USD. For live market cap and overall valuation, see market value of ProMIS Neurosciences Inc..
Annual Strategic Asset Allocation Index for ProMIS Neurosciences Inc. (2018–2021)
The table below presents the year-by-year Strategic Asset Allocation Index for ProMIS Neurosciences Inc. from 2018 to 2021, covering 3 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See ProMIS Neurosciences Inc. shareholders equity for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 0.1% | $5.91K | $5.91K | $0.00 | $7.16 Million | ▲ +0.1 pp |
| 2019 | 0.0% | $0.00 | $- | $0.00 | $398.12K | ▼ -0.2 pp |
| 2018 | 0.2% | $1.89K | $1.89K | $- | $1.16 Million | — |